Top 10 articles for 2023 5 December 2023 Perhaps unsurprisingly the top stories during 2023 were related to the availability, or otherwise, of medications. The nationwide shortage of Ozempic hit the headlines at the start of 2023, and concerns still remain high for those struggling to access a regular supply. Several months later the potential withdrawal of Fiasp from the PBS understandingly sparked angst and distress in the community. These two issues were a major driving force behind the launch of our Spark Change platform. We have committed to fight for change on these issues, plus others. We urge you to add your voice on topics that concern you here. While Ozempic and Fiasp took out the top two spots for the most read articles on our website in 2023, the following eight articles were not far behind. Accessing your HbA1c results online through My Health Record Diabetes Australia welcomes cheaper, more convenient access to medicines Pain, numbness, burning? It could be peripheral neuropathy Recommended vaccinations for those living with type 2 diabetes Bionic pancreas approved by FDA Tube-free insulin pumps Pholcodine withdrawn: What you need to know about cough suppressants this winter Three commonly asked questions about exercise and diabetes
Media releases 30 April 2025 Melbourne to host International Diabetes Congress amid rising health crisis In a major win for Australia’s diabetes community, the International Diabetes Federation Western Pacific Region (IDF WPR) Congress 2026 will... Continue Reading
Media releases 8 April 2025 New data reveals diabetes prevalence in Australia may be 35% higher New research from the University of Sydney reveals that the number of Australians living with diabetes may be up to... Continue Reading
News 3 April 2025 Open letter to the diabetes research community: Investing in the future of diabetes research in Australia In December 2024, we, Diabetes Australia, announced a $40 million investment commitment to diabetes research over the next decade –... Continue Reading